Evaluation of quality improvement for people with diabetes

An evaluation of quality improvement collaboratives aligned to a national audit to improve the uptake of insulin pumps for people with diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN82176651

Enrollment

120

Registered

2022-10-18

Start date

2022-10-18

Completion date

Unknown

Last updated

2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

The intervention comprises a specified and theory-informed Quality Improvement Collaborative delivered alongside the National Diabetes Audit (NDA), involving virtual coaching sessions, workshops and m

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Teams providing specialist diabetes care to adults in England and Wales

Exclusion criteria

Exclusion criteria: Does not meet the inclusion criteria

Design outcomes

Primary

Measure	Time frame
The proportion of adults with poorly controlled type 1 diabetes (HbA1c above 69 mmol/mol) starting and continuing to use insulin pumps for at least 3 months within an 18-month follow-up period	—

Secondary

Measure	Time frame
1. Change in blood glucose levels as measured by HbA1c in people with poorly controlled type 1 diabetes between the latest measurement in the 12 months preceding the start of the intervention and the latest measurements recorded during the study period 2. Any record of insulin pump prescribing, including for periods shorter than 3 months, measured using data routinely collected as part of the National Diabetes Audit over the 18-month follow-up period 3. Insulin pump use sustained over at least 6 months, measured using data routinely collected as part of the National Diabetes Audit over the 18-month follow-up period	—

Measure

Time frame

1. Change in blood glucose levels as measured by HbA1c in people with poorly controlled type 1 diabetes between the latest measurement in the 12 months preceding the start of the intervention and the latest measurements recorded during the study period 2. Any record of insulin pump prescribing, including for periods shorter than 3 months, measured using data routinely collected as part of the National Diabetes Audit over the 18-month follow-up period 3. Insulin pump use sustained over at least 6 months, measured using data routinely collected as part of the National Diabetes Audit over the 18-month follow-up period

—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026